Review Article
Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis
Table 1
Basic characteristic of the included article.
| | Studies | Country | Study year | Tumor type | Cut-off value | Study sample (L/H) | Received therapy | Follow-up time (month) | Prime endpoint | NOS score |
| | Kinoshita 2014 | Japan | 2005-2012 | HCC | 0.037 | 186 (84/102) | Multiply | 18 (1-88) | OS | 7 | | Pang 2017 | China | 2007-2014 | HCC | — | 139 | Surgery | 23.1 (0.4-103.2) | OS/RFS | 7 | | Shimizu 2017 | Japan | 2006-2013 | HCC | 0.028 | 239 (84/155) | Surgery | — | OS/RFS | 8 | | Oh 2018 | Korea | 2004-2013 | HCC | 0.625 | 389 | Surgery | — | OS/RFS | 7 | | Ren 2018 | China | 2012-2017 | HCC | 0.037 | 187 (95/92) | Multiply | 23 (1-60) | OS/TFS | 8 | | Chen 2018 | China | 2013-2016 | HCC | — | 659 | — | 21.6 (1-52.7) | OS | 6 | | Wu 2019 | China | 2008-2012 | HCC | 0.185 | 409 (236/173) | Multiply | Until Jun 30 2016 | OS | 8 |
|
|
HCC: hepatocellular carcinoma; NOS: Newcastle-Ottawa Scale; “-”: not mentioned.
|
